Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig

R Evers1, G J Zaman, L van Deemter

  • 1Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.

Insights

The multidrug resistance-associated protein (MRP) transports anticancer drugs and glutathione conjugates out of cells. Inhibitors of MRP may reverse drug resistance, offering new therapeutic strategies.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Molecular Biology

Background:

  • The human multidrug resistance-associated protein (MRP) is known to confer resistance to cytotoxic drugs by reducing intracellular drug concentrations.
  • Emerging evidence suggests MRP also transports glutathione S-conjugates across cell membranes.

Purpose of the Study:

  • To investigate the transport properties of MRP in intact cells.
  • To determine the localization and function of human MRP expressed in a polarized epithelial cell line.

Main Methods:

  • Human MRP cDNA was expressed in the polarized pig kidney epithelial cell line LLC-PK1.
  • Immunocytochemistry using confocal laser scanning and electron microscopy was employed to determine MRP localization.
  • Transport assays were conducted to measure the movement of glutathione S-conjugates and daunorubicin.

Main Results:

  • MRP was primarily localized to the basolateral plasma membrane of LLC-PK1 cells, not the apical membrane.
  • MRP expression led to increased basolateral transport of S-(2,4-dinitrophenyl)-glutathione and daunorubicin.
  • Sulfinpyrazone and probenecid inhibited MRP-mediated basolateral transport but not MDR1 P-glycoprotein-mediated apical transport.

Conclusions:

  • MRP functions as a basolateral transporter of glutathione S-conjugates and anticancer drugs in polarized epithelial cells.
  • Inhibitors like probenecid and sulfinpyrazone show potential for developing MRP-specific drug resistance reversal agents.
  • Understanding MRP localization and function is crucial for designing targeted cancer therapies.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...